OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation against prostate-specific antigen (PSA) screening in men aged 75 and older on frequency of PSA screening in elderly men.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
DESIGN: Retrospective, cross-sectional analysis.
SETTING: Fifteen community primary care practices in western Massachusetts.
PARTICIPANTS: Men aged 65 and older with one or more annual physicals between January 1, 2006, and December 31, 2010.
MEASUREMENTS: PSA testing was determined from the electronic health record. Mixed-effects logistic regression was used to model the rate of PSA testing over time for two age groups: 65 to 74, and 75 and older.
RESULTS: Of the 7,833 men in this study, 60% were younger than 75. PSA screening rates were consistently lower in men aged 75 and older. Annual rates, adjusted for number of clinic visits, ranged from 12% to 28% in men aged 75 and older, and 37% to 49% in men aged 65 to 74. In the 2 years before the guideline was released, there was already a slow decline in screening rate in men aged 75 and older, whereas the screening rate in men aged 65 to 74 was rising. Compared to 2008, there was a 36% relative reduction in screening rate in 2009 and a 51% relative reduction in 2010 for men aged 75 and older, and a 12% relative reduction in screening rate in 2009 and a 24% relative reduction in 2010 for men aged 65 to 74.
CONCLUSION: The 2008 recommendation appeared to reduce PSA screening rates in older men in 2009 and 2010; there was a substantial reduction in men aged 75 and older and a more modest reduction in men aged 65 to 74.
Lee SY, Friderici J, Stefan MS, Rothberg MB. Are you the author?
Section of Geriatrics, Department of Medicine, School of Medicine, Boston University, Boston Medical Center, Boston, Massachusetts; Section of Hematology/Oncology, Department of Medicine, School of Medicine, Boston University, Boston Medical Center, Boston, Massachusetts.
Reference: J Am Geriatr Soc. 2014 Oct;62(10):1912-5.